pharma news today obesity drugs glp-1 october 2025 Drugmakers are racing to find the next Wegovy. These trials are ones to watch GLP-1 prescriptions for weight loss
Description
This acquisition is aimed at enhancing its portfolio with the addition of Metsera's Next-Generation Obesity Portfolio.
The developmen...
30 Berberine Patches Minimal-effort patches to complement your weight loss journey
What does the current research show
Furthermore, dual-action compounds engaging GLP-1 combined with glucose-dependent insulinotropic polypeptide (GIP) or glucagon pathways, alongside triple agonists incorporating all three receptors activation, have exhibited enhanced therapeutic potential
